Lose Weight With Mounjaro (Tirzepatide)

Mounjaro (Tirzepatide) is used in combination with diet and exercise to achieve weight loss if you’re overweight. It is a once-weekly injection for improving blood sugar in adults.

If your assessment makes you eligible, we may prescribe you a form of mounjaro (tirzepatide) to help you lose weight.

undefined - medication image

What is Mounjaro ?

Mounjaro (Tirzepatide) is a synthetic peptide that mimics the action of two incretin hormones involved in blood sugar control which are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This dual mimetic action makes it the first drug of its kind to act on both of those receptors.

Mounjaro reduces fasting and postprandial glucose concentrations, food intake, and body weight in patients with type 2 diabetic patients, obesity, or excessive body fat.

Wegovy medication

How Does Mounjaro (Tirzepatide) Work?

Mounjaro (Tirzepatide) is a single molecule that stimulates the two natural incretin hormones; insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

GLP-1s stimulate the pancreas to create insulin after meals, which lowers blood sugar levels. They suppress hunger by binding to receptors in the brain that release chemicals which suppress your appetite by stimulating brain locations that regulate food intake. On the other hand, GIP has been demonstrated to reduce your appetite and raise your energy expenditure, resulting in weight loss. The pairing of GIP and GLP-1 agonist may have a greater favorable effect on blood glucose and body weight.

Mounjaro (Tirzepatide) aids weight loss by decreasing food intake and slowing the rate at which food travels through your digestive tract (a process known as gastric emptying). This may help you feel filled for longer periods of time, allowing you to eat less food.

Is Mounjaro effective for weight loss?

'Tirzepatide, the active ingredient in Mounjaro, is a quick, safe, and effective way to lose weight.

It has been shown in clinical trials to help individuals lose up to 21% of their initial body weight when combined with a reduced-calorie diet and increased physical activity, when compared to participants who took a placebo.

Mounjaro (tirzepatide) has numerous advantages, including weight loss and improved control of diabetes symptoms. Weight loss of 20% or more has been demonstrated in clinical trials after a year of treatment with Mounjaro (tirzepatide).

Mounjaro (tirzepatide) is projected to be even more effective than GLP-1 alone, making it an appealing option for anyone seeking safe and effective weight loss options.

How much does Mounjaro cost?

Mounjaro (tirzepatide) may be an expensive medication, costing over $1000.

How is Mounjaro administered?

Mounjaro (tirzepatide) is injected beneath the skin with a standard pen injector syringe. It is injected beneath the skin surface in your stomach, thigh, or upper arm. It is typically administered once weekly, at the same time of day.

Mounjaro (tirzepatide) injections are simple to administer and do not require the assistance of a healthcare practitioner or physician.

Mounjaro (tirzepatide) should be stored in the refrigerator at temperatures ranging from 36°F to 46°F.

At Qilo, if your doctor prescribes Mounjaro (tirzepatide), he or she will walk you through the injection process into your belly or upper thigh. If you are unable to inject yourself, someone else can assist you.

Understanding your MOUNJARO dosage

GLP-1/GIP injectable drugs are provided in a step-up fashion, which means that as you advance through the program, your Qilo healthcare providers will prescribe a greater dose until you reach the complete amount. This reduces the chance of any medication-related negative effects.

Mounjaro (tirzepatide) is available in six distinct dosing strengths. Mounjaro (tirzepatide) is started at a dose of 2.5 mg once a week, and your provider can gradually raise the dose every 4 weeks until you reach the maximum dose of 15 mg.


Side Effects of Mounjaro

The most common side effects described in Mounjaro trials are stomach side effects such as nausea, diarrhea, and loss of appetite. Other side effects of Mounjaro (Tirzepatide) include nausea, constipation, indigestion (heartburn), and stomach (abdominal) pain.

Alternative medication

Mounjaro (tirzepatide) is one of the multiple GLP-1 weight-loss classes of drugs. Other GLP-1 drug classes include: